Incidence and Risk Factors Associated with Outpatient Hypoglycemia in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Study

References

• Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011 Dec;94(3):311–321. doi:10.1016/j.diabres.2011.10.029.
   PubMed Web of Science ®Google Scholar
• Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. Jun 2017;5(6)423–430. doi:10.1016/S2213-8587(17)30097-9.
   PubMed Web of Science ®Google Scholar
• Kaewput W, Thongprayoon C, Mungthin M, et al. Temporal trends in optimal diabetic care and complications of elderly type 2 diabetes patients in Thailand: a nationwide study. J Evid Based Med. 2019;12(1):22–28. doi:10.1111/jebm.12318.
   PubMedGoogle Scholar
• Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009 Jul;32(7):1153–1157. doi:10.2337/dc08-2127.
   PubMed Web of Science ®Google Scholar
• Kaewput W, Thongprayoon C, Varothai N, et al. Prevalence and associated factors of hospitalization for dysglycemia among elderly type 2 diabetes patients: a nationwide study. World J Diabetes. Mar 15 2019;10(3):212–223. doi:10.4239/wjd.v10.i3.212.
   PubMed Web of Science ®Google Scholar
• Kaewput W, Thongprayoon C, Rangsin R, Mao MA, Satirapoj B, Cheungpasitporn W. The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study. Hosp Pract (1995). 2019 Feb;47(1):46–52. doi:10.1080/21548331.2019.1549916.
   PubMedGoogle Scholar
• Kaewput W, Thongprayoon C, Rangsin R, Ruangkanchanasetr P, Mao MA, Cheungpasitporn W. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: a multicenter nationwide cross-sectional study. World J Nephrol. 2019 Feb 21;8(2):33–43. doi:10.5527/wjn.v8.i2.33.
   PubMedGoogle Scholar
• Zelnick LR, Weiss NS, Kestenbaum BR, et al. Diabetes and CKD in the United States Population, 2009-2014. Clin J Am Soc Nephrol. Dec 7 2017;12(12):1984–1990. doi:10.2215/CJN.03700417.
   PubMed Web of Science ®Google Scholar
• Kaewput W, Thongprayoon C, Chewcharat A, et al. Rate of kidney function decline and factors predicting progression of kidney disease in Type 2 diabetes mellitus patients with reduced kidney function: a nationwide retrospective cohort study. Ther Apher Dial. 2020. doi:10.1111/744-9987.13480.
   PubMed Web of Science ®Google Scholar
• Dunkley AJ, Fitzpatrick C, Gray LJ, et al. Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: a UK multisite 12-month prospective observational study. Diabetes Obes Metab. Jul 2019;21(7)1585–1595. doi:10.1111/dom.13690.
   PubMed Web of Science ®Google Scholar
• Alsahli M, Gerich JE. Hypoglycemia in patients with diabetes and renal disease. J Clin Med. 2015 May 13;4(5):948–964. doi:10.3390/jcm4050948.
   PubMed Web of Science ®Google Scholar
• McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012 Sep;35(9):1897–1901. doi:10.2337/dc11-2054.
   PubMed Web of Science ®Google Scholar
• International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. May 2019;7(5):385–396. doi:10.1016/s2213-8587(18)30315-2.
   PubMed Web of Science ®Google Scholar
• Luk AO, Ho TS, Lau ES, et al. Association of self-reported recurrent mild hypoglycemia with incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes: prospective analysis of the Joint Asia Diabetes Evaluation Registry. Medicine (Baltimore). Nov 2016;95(45)e5183. doi:10.1097/MD.0000000000005183.
   PubMed Web of Science ®Google Scholar
• Yu TM, Lin CL, Chang SN, Sung FC, Kao CH. Increased risk of stroke in patients with chronic kidney disease after recurrent hypoglycemia. Neurology. 2014 Aug 19;83(8):686–694. doi:10.1212/WNL.0000000000000711.
   PubMed Web of Science ®Google Scholar
• Sheen YJ, Sheu WH. Association between hypoglycemia and dementia in patients with type 2 diabetes. Diabetes Res Clin Pract. Jun 2016;116:279–287. doi:10.1016/j.diabres.2016.04.004.
   PubMed Web of Science ®Google Scholar
• Lee AK, Rawlings AM, Lee CJ, et al. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia. Sep 2018;61(9)1956–1965. doi:10.1007/s00125-018-4668-1.
   PubMed Web of Science ®Google Scholar
• Pawaskar M, Witt EA, Engel SS, Rajpathak SN, Iglay K. Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe. Endocrinol Diabetes Metab. Apr, 2018;1(2):e00011. doi:10.1002/edm2.11.
   PubMedGoogle Scholar
• Samann A, Lehmann T, Heller T, et al. A retrospective study on the incidence and risk factors of severe hypoglycemia in primary care. Fam Pract. Jun 2013;30(3)290–293. doi:10.1093/fampra/cms071.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. Nov 2012;60(5):850–886. doi:10.1053/j.ajkd.2012.07.005.
   PubMedGoogle Scholar
• Greil C, Roether F, La Rosee P, Grimbacher B, Duerschmied D, Warnatz K. Rescue of cytokine storm due to HLH by hemoadsorption in a CTLA4-deficient patient. J Clin Immunol. [Case Reports Letter Research Support, Non-U.S. Gov’t]. 04 2017;37(3):273–276. doi:10.1007/s10875-017-0377-7.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014 Dec;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. May 5 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Balsam L, Saad C, Arsene C, Fogel J. Impact of autologous stem cell transplantation on blood pressure and renal function in multiple myeloma patients. J Natl Med Assoc. [Evaluation Studies]. 2017 Autumn;109(3):182–191. doi:10.1016/j.jnma.2017.02.010.
   PubMed Web of Science ®Google Scholar
• Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. May 2005;28(5):1245–1249. doi:10.2337/diacare.28.5.1245.
   PubMed Web of Science ®Google Scholar
• Coggon D, Barker D, Rose G. Chapter 2. Quantifying diseases in populations. Epidemiology for the Uninitiated. 4th ed: BMJ Publishing Group Ltd; 2009. https://www.bmj.com/about-bmj/resources-readers/publications/epidemiology-uninitiated/2-quantifying-disease-populations. Accessed on 22 March 2019.
   Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.0158765.
   PubMed Web of Science ®Google Scholar
• Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012 Jul;32(7):613–617. doi:10.1002/j.1875-9114.2011.01088.x.
   PubMed Web of Science ®Google Scholar
• Farrokhi F, Klindukhova O, Chandra P, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. Sep 1 2012;6(5):1022–1029. doi:10.1177/193229681200600505.
   PubMedGoogle Scholar
• Kana Kadayakkara D, Balasubramanian P, Araque K, et al. Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: experience from an academic community hospital. PLoS One. 2019;14(8):e0220956. doi:10.1371/journal.pone.0220956.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, Zhang B, Oh KS, Williams SA, Pollack MF, Graham J. Incidence and cost of hypoglycemia among patients with type 2 diabetes in the United States: analysis of a health insurance database. J Clin Outcomes Manag. 2011;18(10):455–462.
   Google Scholar
• Brod M, Rana A, Barnett AH. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr Med Res Opin. 2012 Dec;28(12):1947–1958. doi:10.1185/03007995.2012.743457.
   PubMed Web of Science ®Google Scholar
• Home P, Naggar NE, Khamseh M, et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. Diabetes Res Clin Pract. Dec 2011;94(3)352–363. doi:10.1016/j.diabres.2011.10.021.
   PubMed Web of Science ®Google Scholar
• Verges B, Brun JM, Tawil C, Alexandre B, Kerlan V. Strategies for insulin initiation: insights from the French LIGHT observational study. Diabetes Metab Res Rev. 2012 Jan;28(1):97–105. doi:10.1002/dmrr.1288.
   PubMed Web of Science ®Google Scholar
• Khunti K, Caputo S, Damci T, et al. The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. Diabetes Obes Metab. Dec 2012;14(12)1129–1136. doi:10.1111/j.1463-1326.2012.01665.x.
   PubMed Web of Science ®Google Scholar
• Khunti K, Alsifri S, Aronson R, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. Sep 2016;18(9)907–915. doi:10.1111/dom.12689.
   PubMed Web of Science ®Google Scholar
• Echtay A, Tsur A, Hasan MI, et al. Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries. Diabetes Ther. Dec 2013;4(2)399–408. doi:10.1007/s13300-013-0041-z.
   PubMed Web of Science ®Google Scholar
• Tsai ST, Pathan F, Ji L, et al. First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. J Diabetes. Sep 2011;3(3)208–216. doi:10.1111/j.1753-0407.2011.00137.x.
   PubMed Web of Science ®Google Scholar
• Ostenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Markert Jensen M, Pedersen-Bjergaard U. Self-reported non-severe hypoglycaemic events in Europe. Diabet Med. 2014 Jan;31(1):92–101. doi:10.1111/dme.12261.
   PubMed Web of Science ®Google Scholar
• Elliott L, Fidler C, Ditchfield A, Stissing T. Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetes Ther. 2016 Mar;7(1):45–60. doi:10.1007/s13300-016-0157-z.
   PubMed Web of Science ®Google Scholar
• Pathak RD, Schroeder EB, Seaquist ER, et al. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011. Diabetes Care. Mar 2016;39(3)363–370. doi:10.2337/dc15-0858.
   PubMed Web of Science ®Google Scholar
• Quilliam BJ, Simeone JC, Ozbay AB, Kogut SJ. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care. Oct 2011;17(10):673–680.
   PubMed Web of Science ®Google Scholar
• Davis TM, Brown SG, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab. 2010 May;95(5):2240–2247. doi:10.1210/jc.2009-2828.
   PubMed Web of Science ®Google Scholar
• Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia–a prospective population-based study. Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):364–369. doi:10.1055/s-2003-42728.
   PubMed Web of Science ®Google Scholar
• Kim HM, Seong JM, Kim J. Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus: interactions between treatment modalities and comorbidities. Medicine (Baltimore). 2016 Oct;95(42):e5016. doi:10.1097/MD.0000000000005016.
   PubMed Web of Science ®Google Scholar
• Quilliam BJ, Simeone JC, Ozbay AB. Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control study. Clin Ther. 2011 Nov;33(11):1781–1791. doi:10.1016/j.clinthera.2011.09.020.
   PubMed Web of Science ®Google Scholar
• Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001 Jul 9;161(13):1653–1659. doi:10.1001/archinte.161.13.1653.
   PubMedGoogle Scholar
• Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. Jun 2009;4(6)1121–1127. doi:10.2215/CJN.00800209.
   PubMed Web of Science ®Google Scholar
• Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet Med. 2003 Aug;20(8):642–645. doi:10.1046/j.1464-5491.2003.01025.x.
   PubMed Web of Science ®Google Scholar
• Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in Type 2 diabetes. Diabet Med. 2008 Mar;25(3):245–254. doi:10.1111/j.1464-5491.2007.02341.x.
   PubMed Web of Science ®Google Scholar
• Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004 May 27;350(22):2272–2279. doi:10.1056/NEJMra031354.
   PubMed Web of Science ®Google Scholar
• Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004 Sep-Oct;17(5):365–370. doi:10.1111/j.0894-0959.2004.17346.x.
   PubMed Web of Science ®Google Scholar
• Holstein A, Hahn M, Stumvoll M, Kovacs P. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes. Horm Metab Res. 2009 May;41(5):387–390. doi:10.1055/s-0029-1192019.
   PubMed Web of Science ®Google Scholar
• Miller ME, Bonds DE, Gerstein HC, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. Jan 2010;8(340)b5444. doi:10.1136/bmj.b5444.
   Google Scholar
• Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. Oct 7 2010;363(15):1410–1418. doi:10.1056/NEJMoa1003795.
   PubMed Web of Science ®Google Scholar
• Yun JS, Ko SH, Ko SH, et al. Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care. May 2013;36(5)1283–1289. doi:10.2337/dc12-1408.
   PubMed Web of Science ®Google Scholar